Crinetics Pharmaceuticals... (CRNX)
NASDAQ: CRNX
· Real-Time Price · USD
30.18
0.49 (1.65%)
At close: Aug 15, 2025, 10:57 AM
Crinetics Pharmaceuticals Fail-to-Deliver
Total FTD Shares
84
Below Average
FTD / Avg. Volume
< 0.01%
Low Impact
1-Year Change
-33.9%
Negative Trend
FTD Chart
As of Jul 7, 2025,
Crinetics Pharmaceuticals Inc. has
84
shares failed to deliver, representing 0.01%
of the average daily volume of
821,720
shares. Over the past year, the monthly average FTD is
4,936
shares, with the current level 98% below
the historical average, indicating
low
settlement pressure. The weighted FTD ratio below 1% suggests normal market making activity with adequate liquidity.
FTD History
| Date | Price | FTD Shares | % Change |
|---|---|---|---|
| Jul 07, 2025 | 29.06 | 84 | -96.42% |
| Jun 26, 2025 | 29.99 | 2.35K | +234400.00% |
| May 20, 2025 | 31.37 | 1 | -99.98% |
| Apr 25, 2025 | 32.39 | 5.87K | +200.97% |
| Mar 13, 2025 | 35.04 | 1.95K | +2533.78% |
| Feb 18, 2025 | 35.53 | 74 | -97.19% |
| Jan 14, 2025 | 35.62 | 2.64K | +1498.79% |
| Dec 26, 2024 | 53.92 | 165 | -89.79% |
| Nov 20, 2024 | 56.07 | 1.62K | +8405.26% |
| Oct 25, 2024 | 57.96 | 19 | -99.94% |
| Sep 27, 2024 | 50.75 | 30.6K | +785.16% |
| Aug 27, 2024 | 54.47 | 3.46K | +115133.33% |
| Jul 30, 2024 | 52.64 | 3 | -97.64% |
| Jun 26, 2024 | 42.19 | 127 | +693.75% |
| May 31, 2024 | 44.41 | 16 | -5.88% |
| Apr 09, 2024 | 46.91 | 17 | +6.25% |
| Mar 28, 2024 | 46.81 | 16 | -97.02% |
| Feb 20, 2024 | 37.42 | 537 | +524.42% |
| Jan 29, 2024 | 37.7 | 86 | +8500.00% |
| Dec 29, 2023 | 35.58 | 1 | -95.65% |
| Nov 16, 2023 | 28.34 | 23 | -98.01% |
| Oct 26, 2023 | 29.22 | 1.15K | +14312.50% |
| Sep 28, 2023 | 29.34 | 8 | -99.58% |
| Aug 14, 2023 | 16.84 | 1.92K | +23.50% |
| Jul 28, 2023 | 18.79 | 1.55K | +45.14% |
| Jun 30, 2023 | 18.02 | 1.07K | +1845.45% |
| May 23, 2023 | 22.54 | 55 | -79.48% |
| Apr 28, 2023 | 19.54 | 268 | -80.86% |
| Mar 31, 2023 | 16.06 | 1.4K | -97.59% |
| Feb 15, 2023 | 19.97 | 58.11K | +3910.49% |
| Jan 31, 2023 | 19.61 | 1.45K | n/a |